Neuroprotective effects of ketorolac tromethamine after spinal cord injury in rats: An ultrastructural study

Advances in Therapy

Volumn 25, Issue 2, 2008, Pages 152-158

  Bagriyanik, Husnu Alper ^a   Ozogul, Candan ^a   Alaygut, Ergin ^a   Gokmen, Necati ^a   Kucukguclu, Semih ^a   Gunerli, Ali ^a   Yilmaz, Osman ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Ketorolac tromethamine; Spinal cord injury; Ultrastructure

Indexed keywords

KETOROLAC TROMETAMOL; KETRODOL; SODIUM CHLORIDE; UNCLASSIFIED DRUG; NEUROPROTECTIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXOPLASM; BRAIN DAMAGE; CONTROLLED STUDY; CYTOPLASM; DRUG DOSE COMPARISON; EDEMA; LAMINECTOMY; MALE; MYELIN SHEATH; NEUROPROTECTION; NONHUMAN; RAT; SPINAL CORD INJURY; ULTRASTRUCTURE ANALYSIS AND ELECTRON MICROSCOPY; WISTAR RAT; ANIMAL; DRUG EFFECT; INTRASPINAL DRUG ADMINISTRATION; PATHOLOGY; SPINAL CORD; ULTRASTRUCTURE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; INJECTIONS, SPINAL; KETOROLAC TROMETHAMINE; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; SPINAL CORD; SPINAL CORD INJURIES;

EID: 58749090751     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12325-008-0018-x     Document Type: Article

References (22)

1. Kwon BK, Fisher CG, Dvorak MF, Tetzlaff W. Strategies to promote neural repair and regeneration after spinal cord injury. Spine. 2005;30:3-13.
2. Hagg T, Oudega M. Degenerative and spontaneous regenerative processes after spinal cord injury. J Neurotrauma. 2006;23:264-280.
3. Gruner JA. A monitored contusion model of spinal cord injury in the rat. J Neurotrauma. 1992;9:123-126.
4. Stokes BT. Experimental spinal cord injury: A dynamic and verifiable injury device. J Neurotrauma. 1992;9:129-131.
5. Joshi M, Fehlings MG. Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: Part 1. Clip design, behavioral outcomes, and histopathology. J Neurotrauma. 2002;19:175-190.
6. Fiford RJ, Bilston LE, Waite P, et al. A vertebral dislocation model of spinal cord injury in rats. J Neurotrauma. 2004;21:451-458.
7. Kwon BK, Oxland TR, Tetzlaff W. Animal models used in spinal cord regeneration research. Spine. 2002;27:1504-1510.
8. Apuzzo M. Pharmacological therapy after acute cervical spinal cord injury. Neurosurgery. 2002;50:63-72.
9. Hugenholtz H, Cass DE, Dvorak MF, et al. High-dose methylprednisolone for acute closed spinal cord injury: Only a treatment option. Can J Neurol Sci. 2002;29:227-235.
10. Gillis JC, Brogden R. Ketorolac: A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management. Drugs. 1997;53:139-188.
11. Jett MF, Ramesha CS, Brown CD, et al. Characterization of the analgesic and anti-inflammatory activities of ketorolac and its enantiomers in the rat. J Pharmacol Exp Ther. 1999;288:1288-1297.
12. Rooks WH 2nd. The pharmacologic activity of ketorolac tromethamine. Pharmacotherapy. 1990;10:30-32.
13. Miranda HF, Sierralta F, Pinardi G. Previous administration of indomethacin or naloxone did not influence ketorolac antinociception in mice. Anesth Analg. 1993;77:750-753.
14. Korkmaz HA, Maltepe F, Erbayraktar S, et al. Antinociceptive and neurotoxicologic screening of chronic intrathecal administration of ketorolac tromethamine in the rat. Anesth Analg. 2004;98:148-152.
15. Yaksh TL, Horais KA, Tozier N, et al. Intrathecal ketorolac in dogs and rats. Toxicol Sci. 2004;80:322-334.
16. Eisenach JC, Curry R, Hood DD, Yaksh TL. Phase I safety assessment of intrathecal ketorolac. Pain. 2002;99:599-604.
17. Hsieh YC, Liang WY, Tsai SK, Wong CS. Intrathecal ketorolac pretreatment reduced spinal cord ischemic injury in rats. Anesth Analg. 2005;100:1134-1139.
18. Yaksh TL, Rudy TA. Chronic catheterization of the spinal subarachnoid space. Physiol Behav. 1976;17:1031-1036.
19. Kwon BK, Tetzlaff W, Grauer JN, Beiner J, Vaccaro AR. Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J. 2004;4:451-464.
20. Akpek E, Bulutcu E, Alanay A, et al. A study of adenosine treatment in experimental acute spinal cord injury. Effect on arachidonic acid metabolites. Spine. 1999;24:128-132.
21. Sharma H, Olsson Y, Cervós-Navarro J. Early perifocal cell changes and edema in traumatic injury of the spinal cord are reduced by indomethacin, an inhibitor of prostaglandin synthesis. Acta Neuropathol. 1993;85:145-153.
22. Kaptanoglu E, Palaoglu S, Surucu HS, Hayran M, Beskonakli E. Ultrastructural scoring of graded acute spinal cord injury in the rat. J Neurosurg. 2002;97:49-56.